Evidence map›Paper›PMID 36716029›Full record

ArticleJAMA network open2023

Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US.

Seth Flaxman, Charles Whittaker, Elizaveta Semenova, Theo Rashid, Robbie M Parks, Alexandra Blenkinsop, H Juliette T Unwin, Swapnil Mishra, Samir Bhatt, Deepti Gurdasani and 1 more

Open access · greenAbstract read
In one paragraph

Article in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Neurological manifestations associated with SARS-CoV-2 infection in pediatric patients: a systematic review.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2025
    Pooled it
  2. Pooled it
  3. Bivalent Omicron BA.4/BA.5 BNT162b2 Vaccine in 6-Month- to <12-Year-Olds.Journal of the Pediatric Infectious Diseases Society · 2024
    Trial
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Observational
  12. COVID-19 and Influenza Deaths in Australian Children 2018-2023: A National Case Analysis.Journal of the Pediatric Infectious Diseases Society · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Seth FlaxmanDepartment of Computer Science, University of Oxford, Oxford, United Kingdom.
Charles WhittakerMRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, United Kingdom.
Elizaveta SemenovaDepartment of Computer Science, University of Oxford, Oxford, United Kingdom.
Theo RashidDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, United Kingdom.
Robbie M ParksDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York.
Alexandra BlenkinsopDepartment of Mathematics, Imperial College London, United Kingdom.
H Juliette T UnwinMRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, United Kingdom.
Swapnil MishraDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.
Samir BhattMRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, United Kingdom.
Deepti GurdasaniQueen Mary University of London, United Kingdom.
Oliver RatmannDepartment of Mathematics, Imperial College London, United Kingdom.
Imperial College London · GBUniversity of Copenhagen · DKUniversity of Oxford · GBColumbia University · USQueen Mary University of London · GB

Funding

Novel Assessments of the Health Impacts of Tropical CyclonesR00ES033742 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PARKS, ROBBIE M · 2023 to 2025
$911k
Novel Assessments of the Health Impacts of Tropical CyclonesK99ES033742 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PARKS, ROBBIE M · 2022 to 2023
$208k
Medical Research Council MC_PC_19012Medical Research Council MR/R015600/1Medical Research Council MR/S003711/1Medical Research Council MR/S003711/2Medical Research Council MR/V038109/1NIEHS NIH HHS K99 ES033742NIEHS NIH HHS R00 ES033742Wellcome Trust 224190/Z/21/Z
6 · The paper itself

Abstract

Importance: COVID-19 was the underlying cause of death for more than 940 000 individuals in the US, including at least 1289 children and young people (CYP) aged 0 to 19 years, with at least 821 CYP deaths occurring in the 1-year period from August 1, 2021, to July 31, 2022. Because deaths among US CYP are rare, the mortality burden of COVID-19 in CYP is best understood in the context of all other causes of CYP death. Objective: To determine whether COVID-19 is a leading (top 10) cause of death in CYP in the US. Design, Setting, and Participants: This national population-level cross-sectional epidemiological analysis for the years 2019 to 2022 used data from the US Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (WONDER) database on underlying cause of death in the US to identify the ranking of COVID-19 relative to other causes of death among individuals aged 0 to 19 years. COVID-19 deaths were considered in 12-month periods between April 1, 2020, and August 31, 2022, compared with deaths from leading non-COVID-19 causes in 2019, 2020, and 2021. Main Outcomes and Measures: Cause of death rankings by total number of deaths, crude rates per 100 000 population, and percentage of all causes of death, using the National Center for Health Statistics 113 Selected Causes of Death, for ages 0 to 19 and by age groupings (<1 year, 1-4 years, 5-9 years, 10-14 years, 15-19 years). Results: There were 821 COVID-19 deaths among individuals aged 0 to 19 years during the study period, resulting in a crude death rate of 1.0 per 100 000 population overall; 4.3 per 100 000 for those younger than 1 year; 0.6 per 100 000 for those aged 1 to 4 years; 0.4 per 100 000 for those aged 5 to 9 years; 0.5 per 100 000 for those aged 10 to 14 years; and 1.8 per 100 000 for those aged 15 to 19 years. COVID-19 mortality in the time period of August 1, 2021, to July 31, 2022, was among the 10 leading causes of death in CYP aged 0 to 19 years in the US, ranking eighth among all causes of deaths, fifth in disease-related causes of deaths (excluding unintentional injuries, assault, and suicide), and first in deaths caused by infectious or respiratory diseases when compared with 2019. COVID-19 deaths constituted 2% of all causes of death in this age group. Conclusions and Relevance: The findings of this study suggest that COVID-19 was a leading cause of death in CYP. It caused substantially more deaths in CYP annually than any vaccine-preventable disease historically in the recent period before vaccines became available. Various factors, including underreporting and not accounting for COVID-19's role as a contributing cause of death from other diseases, mean that these estimates may understate the true mortality burden of COVID-19. The findings of this study underscore the public health relevance of COVID-19 to CYP. In the likely future context of sustained SARS-CoV-2 circulation, appropriate pharmaceutical and nonpharmaceutical interventions (eg, vaccines, ventilation, air cleaning) will continue to play an important role in limiting transmission of the virus and mitigating severe disease in CYP.

Indexed as

Communicable DiseasesCOVID-19AdolescentCause of DeathChildCross-Sectional StudiesHumansSARS-CoV-2

Identifiers

PMID36716029
PMCPMC9887489
OpenAlexW4281571944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.